News
Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna's pivotal trial.
Health officials are making a renewed call for vigilance against bird flu, but some experts are puzzling over why reports of ...
Outbreaks of bird flu in mammals more than doubled across the world last year, raising the risk that the virus could ...
Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback